Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors

被引:9
作者
Gizinska, Malgorzata [1 ]
Staniszewska, Monika [1 ]
Ochal, Zbigniew [2 ]
机构
[1] Natl Inst Hyg, Natl Inst Publ Hlth, Chocimska 24, PL-00791 Warsaw, Poland
[2] Warsaw Univ Technol, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland
关键词
Antifungal activity; anti-virulence agents; Candida spp; fungal infections; sulfone derivatives; virulence; ORGAN TRANSPLANT RECIPIENTS; PRIMARY RESISTANCE; HYDROGEN-PEROXIDE; IN-VITRO; FLUCYTOSINE RESISTANCE; ANTIMICROBIAL PEPTIDES; ASPERGILLUS INFECTIONS; ANTIBACTERIAL ACTIVITY; TARGETING VIRULENCE; FUNGAL-INFECTIONS;
D O I
10.2174/1389557518666180924121209
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Since candidiasis is so difficult to eradicate with an antifungal treatment and the existing antimycotics display many limitations, hopefully new sulfone derivatives may overcome these deficiencies. It is pertinent to study new strategies such as sulfone derivatives targeting the virulence attributes of C. albicans that differentiate them from the host. During infections, the pathogenic potential of C. albicans relies on the virulence factors as follows: hydrolytic enzymes, transcriptional factors, adhesion, and development of biofilms. In the article we explored how the above-presented C. albicans fitness and virulence attributes provided a robust response to the environmental stress exerted by sulfones upon C. albicans; C. albicans fitness and virulence attributes are fungal properties whose inactivation attenuates virulence. Our understanding of how these mechanisms and factors are inhibited by sulfones has increased over the last years. As lack of toxicity is a prerequisite for medical approaches, sulfones (non-toxic as assessed in vitro and in vivo) may prove to be useful for reducing C. albicans pathogenesis in humans. The antifungal activity of sulfones dealing with these multiple virulence factors and fitness attributes is discussed.
引用
收藏
页码:12 / 21
页数:10
相关论文
共 114 条
  • [61] Candida albicans Biofilms and Human Disease
    Nobile, Clarissa J.
    Johnson, Alexander D.
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, VOL 69, 2015, 69 : 71 - 92
  • [62] A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
    Nobile, Clarissa J.
    Fox, Emily P.
    Nett, Jeniel E.
    Sorrells, Trevor R.
    Mitrovich, Quinn M.
    Hernday, Aaron D.
    Tuch, Brian B.
    Andes, David R.
    Johnson, Alexander D.
    [J]. CELL, 2012, 148 (1-2) : 126 - 138
  • [63] Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey
    Nucci, Marcio
    Queiroz-Telles, Flavio
    Alvarado-Matute, Tito
    Nora Tiraboschi, Iris
    Cortes, Jorge
    Zurita, Jeannete
    Guzman-Blanco, Manuel
    Elena Santolaya, Maria
    Thompson, Luis
    Sifuentes-Osornio, Jose
    Echevarria, Juan I.
    Colombo, Arnaldo L.
    [J]. PLOS ONE, 2013, 8 (03):
  • [64] Ochal Z., 2009, PL Pat, Patent No. [202745 B1, 202745]
  • [65] Ochal Z., 2014, PL Pat, Patent No. [P. 408200, 408200]
  • [66] Ochal Z., 2005, Pol. J. Appl. Chem, V49, P215
  • [67] Ochal Z, 2013, MED CHEM, V9, P1129
  • [68] Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
  • [69] Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital
    Peron, Isabela Haddad
    Reichert-Lima, Franqueline
    Busso-Lopes, Ariane Fidelis
    Nagasako, Cristiane Kibune
    Lyra, Luzia
    Moretti, Maria Luiza
    Schreiber, Angelica Zaninelli
    [J]. PLOS ONE, 2016, 11 (07):
  • [70] Fungal Morphogenetic Pathways Are Required for the Hallmark Inflammatory Response during Candida albicans Vaginitis
    Peters, Brian M.
    Palmer, Glen E.
    Nash, Andrea K.
    Lilly, Elizabeth A.
    Fidel, Paul L., Jr.
    Noverr, Mairi C.
    [J]. INFECTION AND IMMUNITY, 2014, 82 (02) : 532 - 543